106792-29-4

Usage

Uses

Used in Pharmaceutical Industry:
1,2,3,4-Tetrahydro-benzofuro[2,3-c]pyridine is used as a drug lead or pharmacological tool for the development of new therapeutic agents. Its unique structure and potential pharmacological properties make it a valuable target for chemical synthesis and exploration of its biological activities.
Used in Medicinal Chemistry Research:
1,2,3,4-Tetrahydro-benzofuro[2,3-c]pyridine is used in medicinal chemistry research to investigate its potential applications in the treatment of various diseases and conditions. Further research is necessary to understand its full potential and properties, which may lead to the discovery of new therapeutic agents.
Used in Chemical Synthesis:
1,2,3,4-Tetrahydro-benzofuro[2,3-c]pyridine is used as a valuable target for chemical synthesis, allowing researchers to explore its structure and modify it to develop new compounds with potential therapeutic applications.

InChI:InChI=1/C11H11NO/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,12H,5-7H2

Upstream product

• 40114-49-6 1-benzyl-3-piperidone 
• 50-00-0 formaldehyd 
• 27404-31-5 2-(benzofuran-3-yl)ethanamine 
• 907566-92-1 methyl 3,4-dihydrobenzofuro[2,3-c]pyridine-2(1H)-carboxylate 

Relevant academic research and scientific papers

PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES

Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues of the formula (I): are provided, as are methods for their preparation and use. Such compounds may generally be used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and therapeutic methods are provided, as are methods for using such ligands for detecting histamine H3 receptors (e.g., receptor localization studies).

FUSED HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF HISTONE DEACETYLASE

Disclosed are compounds of formula (I) that inhibit histone deacetylase (HDAC) enzymatic activity, pharmaceutical compositions comprising such compounds, as well as methods to treat conditions, particularly proliferative conditions, mediated at least in part by HDAC, wherein A, W, W1, W2, Ar2, and G are described herein.

Indole derivatives

New indole derivatives of the general formula I STR1 in which Ind is a 3-indolyl radical which can be substituted by a hydroxymethyl, methylenedioxy, S-alkyl, SO-alkyl, SO2 -alkyl, CN or COW group and/or can be substituted once or twice by alkyl, O-alkyl, OH, F, Cl or Br, W is H, OH, O-alkyl, NH2, NH-alkyl or N(alkyl)2, A is --(CH2)n --, --CH2 --S--CH2 CH2 --, --CH2 --SO--CH2 CH2 -- or --CH2 --SO2 --CH2 CH2 --, is --(CH2)m --, --CH=CH--, --CHOH--, --CO--, S, SO, SO2 or O, n is 2, 3, 4 or 5 and m is 1, 2 or 3, in which the alkyl groups each have 1-4 C atoms, and their salts, have effects on the central nervous system.